Evidence map›Paper›PMID 30048844›Full record

ArticleSocial science & medicine (1982)2018

Childhood socioeconomic status and genetic risk for poorer cognition in later life.

Sara M Moorman, Kyle Carr, Emily A Greenfield

Abstract read
In one paragraph

Article in Social science & medicine (1982), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Beneficial Effect of Societal Factors on APOE-ε2 and ε4 Carriers' Brain Health: A Systematic Review.The journals of gerontology. Series A, Biological sciences and medical sciences · 2024
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Early-Life Maternal Relationship Quality and Cognitive Function in Later Life: Mediating Role of Social Resources?The journals of gerontology. Series B, Psychological sciences and social sciences · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Pathways From Early-Life SES to Dementia Risk in Old Age: The Role of Personality.The journals of gerontology. Series B, Psychological sciences and social sciences · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Using Mixture Modeling to Construct Subgroups of Cognitive Aging in the Wisconsin Longitudinal Study.The journals of gerontology. Series B, Psychological sciences and social sciences · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. The Neuroscience of Socioeconomic Inequality.Current opinion in behavioral sciences · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sara M MoormanDepartment of Sociology, Boston College, United States. Electronic address: moormans@bc.edu.
Kyle CarrDepartment of Sociology, Boston College, United States.
Emily A GreenfieldSchool of Social Work Rutgers, The State University of New Jersey, United States.

Funding

Genomics for Social Scientists: 2022-2027R25AG053227 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Jessica Faul, COLTER M.S. MITCHELL · 2016 to 2026
$1.6M
Optimizing Cognitive Health in Later Life by Examining Childhood Socioeconomic Status as an Early-Life Risk and Protective Factor SupplementR01AG057491 · NIA · RUTGERS, THE STATE UNIV OF N.J. · PI COHEN, EMILY GREENFIELD, MOORMAN, SARA M · 2017 to 2019
$1.1M
NIA NIH HHS R01 AG057491NIA NIH HHS R25 AG053227
6 · The paper itself

Abstract

The ε4 allele of the APOE gene is associated with poorer cognition in later life. This study aimed to advance understanding of how environments potentially moderate this genetic risk by focusing on childhood socioeconomic status (SES). Previous research across diverse national contexts has found that older adults from higher-SES families in childhood demonstrate better cognitive functioning than their lower-SES counterparts. Nevertheless, few studies have examined whether higher childhood SES might also promote later life cognition by mitigating the effects of ε4 carrier status. To address this gap, we used data from 3017 participants in the Wisconsin Longitudinal Study, which has followed a random sample of people who graduated from Wisconsin high schools in 1957. Childhood SES included parents' educational attainment, father's occupational status, and household income in adolescence. We constructed measures of memory and of language/executive functioning using scores from neurocognitive tests administered when participants were approximately ages 65 and 72. APOE ε4 status was measured through saliva samples. Results from cross-controlled multilevel models indicated that APOE ε4 status-and not childhood SES-independently predicted memory, whereas childhood SES-and not APOE ε4 status-independently predicted language/executive functioning. Moreover, a statistical interaction between APOE ε4 status and childhood SES for memory indicated that at baseline, higher childhood SES protected against the risk of APOE ε4 status, whereas lower childhood SES exacerbated the risk of APOE ε4 status. However, by follow-up, these moderating effects dissipated, and APOE ε4 status alone was associated with memory. We interpret these results in light of theorizing on differential susceptibility for poorer cognition across the life course.

Indexed as

Gene-Environment InteractionGenetic Predisposition to DiseaseSocial ClassAgedApolipoprotein E4ChildCognition DisordersExecutive FunctionFemaleHumansLanguageLongitudinal StudiesMaleMemoryMental Status and Dementia TestsSalivaApolipoprotein E4Apolipoprotein ECognitive agingDifferential susceptibilityGene-by-environment interactionsLife course perspectiveSocioeconomic statusU.S.Wisconsin longitudinal study

Identifiers

PMID30048844
PMCPMC6536306

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.